Belatacept

Records for this ingredient, by country (identity only).

ATC L04AA28 · 7 markets · 7 records

Belatacept 7 markets · 7 records Forms

Filters

MarketUS 1 GB 1 AU 1 ES 1 EU 1 FR 1

Strength

US 1 records · 1 shown of 1 Source openFDA NDC Directory · Data as of 2026-10-23

250 mg per mL / per unit basis not statedinjectionNULOJIX

GB 1 records · 1 shown of 1 Source NHSBSA dm+d · Data as of 2026-10-19

250 mg per mL / per unit basis not statedinjectionNulojix 250mg powder for concentrate for solution for infusion vials

AU 1 records · 1 shown of 1 Source TGA · Data as of 2026-10-28 · includes records with unknown status (not proof of sale)

250 mg per mL / per unit basis not statedinjectionNULOJIX belatacept (rch) 250mg powder for IV infusion vial unknown

ES 1 records · 1 shown of 1 Source CIMA (AEMPS) · Data as of live

250 mg per mL / per unit basis not statedinjectionNULOJIX

EU 1 records · 0 shown of 0 Source European Commission · Data as of 2026-11-03 · some records have no stated strength

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名NULOJIX ×1

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

FR 1 records · 1 shown of 1 Source Base de données publique des médic · Data as of 2026-11-03

250 mg per mL / per unit basis not statedinjectionNULOJIX 250 mg, poudre pour solution à diluer pour perfusion

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

Side-by-side table

Strength / form / release	US	GB	AU	ES	EU	FR
250 mg per mL / per unit basis not stated cannot compare injection	NULOJIX	Nulojix 250mg powder for concentrate for solution for infusion vials	NULOJIX belatacept (rch) 250mg powder for IV infusion vial	NULOJIX	not recorded	NULOJIX 250 mg, poudre pour solution à diluer pour perfusion
not disclosed unknown	not recorded	not recorded	not recorded	not recorded	NULOJIX	not recorded

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

1 more strength/form rows are recorded only in EU and are not shown in this table. Hay 1 filas de concentración/forma registradas solo en EU que no se muestran en esta tabla. 另有 1 个规格/剂型仅在 EU 有记录（未在本表显示）。另有 1 個規格/劑型僅在 EU 有記錄（未在本表顯示）。

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.